Epigral Limited
Dr. Mahendra Rane is a highly experienced professional in the field of polymers with significant expertise in business development, technical solutions, and market strategies across multiple industries. Currently serving as Business Unit Head - AGM at Meghmani Finechem Limited since November 2022, Dr. Rane is responsible for sales generation and revenue growth in the EU and APAC markets, focusing on epichlorohydrin applications in key industries. Previous roles include Head of LabTec at Mettler-Toledo International, where leadership and market development led to notable revenue growth, and various technical and managerial positions at Fine Organic Industries, Omya, LANXESS, Technische Universität Chemnitz, and BASF. Dr. Rane holds multiple advanced degrees in Polymer Science and Materials Sciences from prestigious institutions, enriching a career marked by strategic innovation and industry impact.
This person is not in any teams
This person is not in any offices
Epigral Limited
1 followers
Epigral Limited (Epigral), formerly known as Meghmani Finechem Ltd, incorporated in 2007, is a leading integrated manufacturer of chemicals in India. The company has futuristic manufacturing facilities in Gujarat, Dahej – a leading PCPIR region in the country. Epigral’s Dahej facility is a backward and forward integrated and automated complex with a well-established infrastructure and Captive Power Plants. In India, Epigral is the 1st to set up an Epichlorohydrin plant and largest capacity plant of CPVC Resin. Epigral is India’s 4th largest manufacturer of Caustic Soda, Chlorine and Hydrogen and a leading manufacturer of Caustic Potash, Chloromethanes and Hydrogen Peroxide. Epigral is strengthening its position in the specialty chemical segment by expanding CPVC Resin capacity to 75,000 TPA, setting up CPVC compound capacity of 35,000 TPA, entering into the Chlorotoluene & value chain and setting up R & D centre. The company is focused on sustainable value creation for all its stakeholders and has been awarded with the Responsible Care certificate. Through integral collaborations and exceptional solutions, Epigral strives to enhance value and exceed expectations, transforming the company as a global multi-product chemical conglomerate.